Sullivan C J, Jordan M C
University of Minnesota Medical School, Minneapolis 55455.
Semin Respir Infect. 1988 Jun;3(2):148-61.
The diagnosis of viral pneumonia has changed during the past decade from a purely clinical diagnosis to one that is both clinical and laboratory in nature. Viral pneumonias can be divided into two clinical groups: the so-called "atypical" pneumonias in otherwise normal hosts, and viral pneumonitis in the immunocompromised host. Clinical factors such as patient age, immune status, time of year, illness in other family members, community outbreaks, onset, severity, duration of symptoms, and the presence of a rash remain important aids in diagnosing viral causes of both atypical pneumonia and pneumonia in the immunocompromised patient. However, advances in virus culture methodologies and the use of monoclonal antibodies coupled with immunofluorescence and ELISA techniques have markedly enhanced both the sensitivity, specificity, and rapidity of the diagnosis of viral pneumonias. Further advances are expected in the future as nucleic acid hybridization techniques are increasingly applied to both viral cultures and direct analysis of clinical specimens.
在过去十年中,病毒性肺炎的诊断已从单纯的临床诊断转变为兼具临床和实验室诊断性质的诊断。病毒性肺炎可分为两个临床组:在其他方面正常宿主中的所谓“非典型”肺炎,以及免疫功能低下宿主中的病毒性肺炎。诸如患者年龄、免疫状态、一年中的时间、其他家庭成员的疾病、社区疫情、发病情况、严重程度、症状持续时间以及皮疹的出现等临床因素,仍然是诊断免疫功能低下患者非典型肺炎和肺炎的病毒病因的重要辅助手段。然而,病毒培养方法的进步以及单克隆抗体与免疫荧光和酶联免疫吸附测定技术的结合,显著提高了病毒性肺炎诊断的敏感性、特异性和快速性。随着核酸杂交技术越来越多地应用于病毒培养和临床标本的直接分析,预计未来还会有进一步的进展。